Lacnotuzumab

Tax included
Lacnotuzumab (MCS110) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1 that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis.
MedChemExpress 
HY-P99368

Data sheet

Size
Multiple sizes
Reactivity
c-Fms
CAS
1831128-32-5